| 1 |
Chen TI, Lee FJ, Hsu WL, Chen YC, Chen M. Association of Dipeptidyl Peptidase-4 Inhibitors Use with Reduced Risk of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Chronic HBV Infection. Cancers (Basel) 2023;15. [PMID: 36831491 DOI: 10.3390/cancers15041148] [Reference Citation Analysis]
|
| 2 |
Cernea S, Onișor D. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma. World J Gastroenterol 2023; 29(2): 286-309 [PMID: 36687124 DOI: 10.3748/wjg.v29.i2.286] [Reference Citation Analysis]
|
| 3 |
Nithya V, Sangavi P, Srinithi R, Nachammai KT, Gowtham Kumar S, Prabu D, Langeswaran K. Diabetes and Other Comorbidities: Microvascular and Macrovascular Diseases Diabetes and Cancer. Advances in Diabetes Research and Management 2023. [DOI: 10.1007/978-981-19-0027-3_2] [Reference Citation Analysis]
|
| 4 |
Nakatsuka T, Tateishi R. Development and prognosis of hepatocellular carcinoma in patients with diabetes. Clin Mol Hepatol 2023;29:51-64. [PMID: 35903020 DOI: 10.3350/cmh.2022.0095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Onikanni SA, Lawal B, Bakare OS, Ajiboye BO, Ojo OA, Farasani A, Kabrah SM, Batiha GE, Conte-Junior CA. Cancer of the Liver and its Relationship with Diabetes mellitus. Technol Cancer Res Treat 2022;21:15330338221119743. [PMID: 36533882 DOI: 10.1177/15330338221119743] [Reference Citation Analysis]
|
| 6 |
Yang SY, Yan ML, Feng JK, Duan YF, Ye JZ, Liu ZH, Guo L, Xue J, Shi J, Lau WY, Cheng SQ, Guo WX. Impact of type 2 diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: A multicenter retrospective study. Front Oncol 2022;12:979434. [PMID: 36591472 DOI: 10.3389/fonc.2022.979434] [Reference Citation Analysis]
|
| 7 |
Plaz Torres MC, Jaffe A, Perry R, Marabotto E, Strazzabosco M, Giannini EG. Diabetes medications and risk of HCC. Hepatology 2022;76:1880-97. [PMID: 35239194 DOI: 10.1002/hep.32439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 8 |
Vishnubhotla R, Kulkarni AV, Sharma M, Rao PN, Reddy DN. An update on the genetics of alcoholic liver disease. Front Gastroenterol 2022;1. [DOI: 10.3389/fgstr.2022.1030399] [Reference Citation Analysis]
|
| 9 |
Chou OHI, Ning J, Chiu Chan RN, Chung CT, Huang H, Ng K, Dee EC, Lee S, Kaewdech A, Liu T, Jing F, Yung Cheung BM, Tse G, Zhou J. Lower risks of sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset non-alcoholic fatty liver disease and hepatocellular carcinoma in type 2 diabetes mellitus: A population-based study.. [DOI: 10.1101/2022.08.16.22278847] [Reference Citation Analysis]
|
| 10 |
Ma J, Li J, Yao D, Wang Q, Chen X, Tao F, Chen B, Xie Y, Bai L, Zhang Y, Perrone MG. Design, Synthesis, and Biological Evaluation of Novel Pyrrolo [2,3-b] Pyridine Derivatives for Nonalcoholic Fatty Liver Disease. Journal of Chemistry 2022;2022:1-12. [DOI: 10.1155/2022/2386212] [Reference Citation Analysis]
|
| 11 |
Li N, Zheng X, Chen M, Huang L, Chen L, Huo R, Li X, Huang Y, Sun M, Mai S, Wu Z, Zhang H, Liu J, Yang CT. Deficient DNASE1L3 facilitates neutrophil extracellular traps-induced invasion via cyclic GMP-AMP synthase and the non-canonical NF-κB pathway in diabetic hepatocellular carcinoma. Clin Transl Immunology 2022;11:e1386. [PMID: 35474906 DOI: 10.1002/cti2.1386] [Reference Citation Analysis]
|
| 12 |
Maddah R, Shariati P, Arabpour J, Bazireh H, Shadpirouz M, Kafraj AS. Identification of critical genes and pathways associated with hepatocellular carcinoma and type 2 diabetes mellitus using integrated bioinformatics analysis. Informatics in Medicine Unlocked 2022;30:100956. [DOI: 10.1016/j.imu.2022.100956] [Reference Citation Analysis]
|
| 13 |
Popescu-Vâlceanu HC, Stoicea MC, Enache V, Bratu RM, Mustăţea P, Drăguţ RM, Rusu E, Ionescu-Tîrgovişte C, Radulian G. Bcl-2 and p53 immunophenotypes in colorectal adenocarcinoma in type 2 diabetes mellitus versus non-diabetic patients. Rom J Morphol Embryol 2022;63:521-8. [PMID: 36588490 DOI: 10.47162/RJME.63.3.06] [Reference Citation Analysis]
|
| 14 |
Jaffe A, Strazzabosco M. Metabolic Syndrome and Liver Cancer. Hepato-Pancreato-Biliary Malignancies 2022. [DOI: 10.1007/978-3-030-41683-6_51] [Reference Citation Analysis]
|
| 15 |
Apostolopoulou M, Roden M. Therapie von Begleiterkrankungen: Diabetes mellitus und Dyslipoproteinämie. Nicht-alkoholische Fettlebererkrankung 2022. [DOI: 10.1007/978-3-662-62484-5_20] [Reference Citation Analysis]
|
| 16 |
Ichimura-Shimizu M, Kageyama T, Oya T, Ogawa H, Matsumoto M, Sumida S, Kakimoto T, Miyakami Y, Nagatomo R, Inoue K, Cheng C, Tsuneyama K. Verification of the Impact of Blood Glucose Level on Liver Carcinogenesis and the Efficacy of a Dietary Intervention in a Spontaneous Metabolic Syndrome Model. Int J Mol Sci 2021;22:12844. [PMID: 34884650 DOI: 10.3390/ijms222312844] [Reference Citation Analysis]
|
| 17 |
Gavril OI, Arhire LI, Gavril RS, Zota MI, Gherasim A, Nita O, Drugescu A, Oprescu AC, Esanu IM, Mitu F, Graur M, Mihalache L. Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients. Medicina (Kaunas) 2021;57:1249. [PMID: 34833467 DOI: 10.3390/medicina57111249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 18 |
Wang X, Ding S. The biological and pharmacological connections between diabetes and various types of cancer. Pathol Res Pract 2021;227:153641. [PMID: 34619575 DOI: 10.1016/j.prp.2021.153641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 19 |
Czarnecka K, Czarnecka P, Tronina O, Bączkowska T, Durlik M. Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation. Immun Inflamm Dis 2021. [PMID: 34598315 DOI: 10.1002/iid3.538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Dinani A, Sussman N, Noureddin M, Fuchs M, Therapondos G, Girgrah N, Diaz VF, Mantry P, Rinella M, Asgharpour A, Dieterich D. An algorithm for the management of non-alcoholic fatty liver disease in primary care. GHOA 2021;12:114-122. [DOI: 10.15406/ghoa.2021.12.00469] [Reference Citation Analysis]
|
| 21 |
Zhou J, Ke Y, Lei X, Wu T, Li Y, Bao T, Tang H, Zhang C, Wu X, Wang G, Li J, Zhang H, Ni F, Ye Z, Wang L. Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes. Ann Hepatol 2020;19:320-8. [PMID: 31980358 DOI: 10.1016/j.aohep.2019.11.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 22 |
Durrani IA, Bhatti A, John P. Regulatory MicroRNAs in T2DM and Breast Cancer. Processes 2021;9:819. [DOI: 10.3390/pr9050819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Bi Y, Yin B, Fan G. Identification of metabolism genes related to hepatocarcinogenesis and progression in type 2 diabetes mellitus via co-expression networks analysis. Hereditas 2021;158:14. [PMID: 33865459 DOI: 10.1186/s41065-021-00177-x] [Reference Citation Analysis]
|
| 24 |
Tangjarusritaratorn T, Tangjittipokin W, Kunavisarut T. Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin. Diabetes Metab Syndr Obes 2021;14:1563-74. [PMID: 33859487 DOI: 10.2147/DMSO.S295753] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 25 |
Rimassa L, Personeni N, Czauderna C, Foerster F, Galle P. Systemic treatment of HCC in special populations. J Hepatol 2021;74:931-43. [PMID: 33248171 DOI: 10.1016/j.jhep.2020.11.026] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 26 |
Zhou M, Hou Y, Wu J, Li G, Cao P, Chen W, Hu L, Gan D. miR-93-5p promotes insulin resistance to regulate type 2 diabetes progression in HepG2 cells by targeting HGF. Mol Med Rep 2021;23:329. [PMID: 33760164 DOI: 10.3892/mmr.2021.11968] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 27 |
Chou YT, Li CH, Sun ZJ, Shen WC, Yang YC, Lu FH, Chang CJ, Wu JS. A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones. Nutrients 2021;13:914. [PMID: 33799865 DOI: 10.3390/nu13030914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 28 |
Campbell C, Wang T, McNaughton AL, Barnes E, Matthews PC. Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis. J Viral Hepat 2021;28:493-507. [PMID: 33305479 DOI: 10.1111/jvh.13452] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 29 |
Shi T, Kobara H, Oura K, Masaki T. Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes. J Hepatocell Carcinoma 2021;8:45-55. [PMID: 33604315 DOI: 10.2147/JHC.S274933] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 30 |
Kucukoglu O, Sowa JP, Mazzolini GD, Syn WK, Canbay A. Hepatokines and adipokines in NASH-related hepatocellular carcinoma. J Hepatol 2021;74:442-57. [PMID: 33161047 DOI: 10.1016/j.jhep.2020.10.030] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 31 |
Cernea S, Raz I. NAFLD in type 2 diabetes mellitus: Still many challenging questions. Diabetes Metab Res Rev 2021;37:e3386. [PMID: 32677717 DOI: 10.1002/dmrr.3386] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 32 |
Jaffe A, Strazzabosco M. Metabolic Syndrome and Liver Cancer. Hepato-Pancreato-Biliary Malignancies 2021. [DOI: 10.1007/978-3-030-37482-2_51-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 33 |
Shah I, Khan SA, Hussain S, Khan F, Niaz K. Liver cancer. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases 2021. [DOI: 10.1016/b978-0-12-816488-4.00004-8] [Reference Citation Analysis]
|
| 34 |
Shafqat F, Khan MNA, Shafqat S. SmartHealth: IoT-Enabled Context-Aware 5G Ambient Cloud Platform. IoT in Healthcare and Ambient Assisted Living 2021. [DOI: 10.1007/978-981-15-9897-5_3] [Reference Citation Analysis]
|
| 35 |
Pericot-Valverde I, Heo M, Akiyama MJ, Norton BL, Agyemang L, Niu J, Litwin AH. Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial. BMC Infect Dis 2020;20:928. [PMID: 33276738 DOI: 10.1186/s12879-020-05667-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 36 |
Dewidar B, Kahl S, Pafili K, Roden M. Metabolic liver disease in diabetes - From mechanisms to clinical trials. Metabolism 2020;111S:154299. [PMID: 32569680 DOI: 10.1016/j.metabol.2020.154299] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 19.3] [Reference Citation Analysis]
|
| 37 |
Giglio RV, Nikolic D, Volti GL, Stoian AP, Banerjee Y, Magan-Fernandez A, Castellino G, Patti AM, Chianetta R, Castracani CC, Montalto G, Rizvi AA, Sesti G, Rizzo M. Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect. Metabolites 2020;10:E391. [PMID: 33008044 DOI: 10.3390/metabo10100391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 38 |
Campbell C, Wang T, Mcnaughton A, Barnes E, Matthews PC. Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis.. [DOI: 10.1101/2020.08.21.20179234] [Reference Citation Analysis]
|
| 39 |
Ogawa M, Tsuchiya A, Watanabe T, Setsu T, Kimura N, Matsuda M, Hoshiyama Y, Saito H, Kanazawa T, Shiotani M, Sato T, Yagi T, Igarashi K, Yoshimura N, Takamura M, Aoyama H, Terai S. Screening and follow-up of chronic liver diseases with understanding their etiology in clinics and hospitals. JGH Open 2020;4:827-37. [PMID: 33102751 DOI: 10.1002/jgh3.12406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Bayrak BB, Koroglu P, Karabulut Bulan O, Yanardag R. Metformin protects against diabetes-induced heart injury and dunning prostate cancer model. Hum Exp Toxicol 2021;40:297-309. [PMID: 32812462 DOI: 10.1177/0960327120947452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Mantovani A, Targher G, Zoppini G. Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes. Clinics in Geriatric Medicine 2020;36:527-47. [DOI: 10.1016/j.cger.2020.04.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Liang KH, Cheng ML, Lo CJ, Lin YH, Lai MW, Lin WR, Yeh CT. Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study. Sci Rep 2020;10:10926. [PMID: 32616821 DOI: 10.1038/s41598-020-67971-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 43 |
Wang M, Yang Y, Liao Z. Diabetes and cancer: Epidemiological and biological links. World J Diabetes 2020; 11(6): 227-238 [PMID: 32547697 DOI: 10.4239/wjd.v11.i6.227] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 58] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 44 |
Ahmed Mobasher M, Galal El-Tantawi H, Samy El-Said K. Metformin Ameliorates Oxidative Stress Induced by Diabetes Mellitus and Hepatocellular Carcinoma in Rats. Rep Biochem Mol Biol 2020;9:115-28. [PMID: 32821759 DOI: 10.29252/rbmb.9.1.115] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 45 |
Hester D, Golabi P, Paik J, Younossi I, Mishra A, Younossi ZM. Among Medicare Patients With Hepatocellular Carcinoma, Non-alcoholic Fatty Liver Disease is the Most Common Etiology and Cause of Mortality. J Clin Gastroenterol 2020;54:459-67. [PMID: 30672817 DOI: 10.1097/MCG.0000000000001172] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 46 |
Mani M, Vijayaraghavan S, Sarangan G, Raguramachandran A, Srikanth P. Hepatitis B virus genotype D in T2DM: A report from a tertiary care centre, Chennai. Obesity Medicine 2020;17:100160. [DOI: 10.1016/j.obmed.2019.100160] [Reference Citation Analysis]
|
| 47 |
Ferreira G, Stuurman AL, Horsmans Y, Cattaert T, Verstraeten T, Feng Y, Rosillon D, Guignard A. Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink. Eur J Gastroenterol Hepatol 2020;32:101-9. [PMID: 31651649 DOI: 10.1097/MEG.0000000000001537] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 48 |
Li L, Cheng Y, Lin L, Liu Z, Du S, Ma L, Li J, Peng Z, Yan J. Global Analysis of miRNA Signature Differentially Expressed in Insulin-resistant Human Hepatocellular Carcinoma Cell Line. Int J Med Sci 2020;17:664-77. [PMID: 32210717 DOI: 10.7150/ijms.41999] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 49 |
Niccum BA, Stine JG, Wynter JA, Kelly V, Caldwell SH, Shah NL. Success of Direct-Acting, Antiviral-Based Therapy for Chronic Hepatitis C Is Not Affected by Type 2 Diabetes. Clinical Diabetes 2020;38:40-46. [DOI: 10.2337/cd18-0112] [Reference Citation Analysis]
|
| 50 |
Raza S, Rajak S, Anjum B, Sinha RA. Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma. Hepatoma Res 2019;5:42. [PMID: 31867441 DOI: 10.20517/2394-5079.2019.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 51 |
Xia H, Chen J, Sekar K, Shi M, Xie T, Hui KM. Clinical and metabolomics analysis of hepatocellular carcinoma patients with diabetes mellitus. Metabolomics 2019;15:156. [PMID: 31773292 DOI: 10.1007/s11306-019-1619-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 52 |
Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. World J Gastroenterol 2019; 25(42): 6322-6341 [PMID: 31754293 DOI: 10.3748/wjg.v25.i42.6322] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 53 |
Xu C, Chen J, Zhang PA. Relationship Between Diabetes Mellitus and Cirrhosis Risk in Chronic Hepatitis B Patients in Wuhan, China. Med Sci Monit. 2019;25:8112-8119. [PMID: 31661471 DOI: 10.12659/msm.917000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 54 |
Fekry B, Ribas-Latre A, Baumgartner C, Mohamed AMT, Kolonin MG, Sladek FM, Younes M, Eckel-Mahan KL. HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma. Cancer Res 2019;79:5860-73. [PMID: 31575546 DOI: 10.1158/0008-5472.CAN-19-1277] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 55 |
Marsella M, Ricchi P. Thalassemia and hepatocellular carcinoma: links and risks. J Blood Med 2019;10:323-34. [PMID: 31572038 DOI: 10.2147/JBM.S186362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 56 |
Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol 2019;16:411-28. [PMID: 31028350 DOI: 10.1038/s41575-019-0145-7] [Cited by in Crossref: 558] [Cited by in F6Publishing: 549] [Article Influence: 139.5] [Reference Citation Analysis]
|
| 57 |
Roos JF, Qudsi M, Samara A, Rahim MM, Al-bayedh SA, Ahmed H. Metformin for lung cancer prevention and improved survival: a novel approach. European Journal of Cancer Prevention 2019;28:311-5. [DOI: 10.1097/cej.0000000000000442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 58 |
Ma HP, Chang HL, Bamodu OA, Yadav VK, Huang TY, Wu ATH, Yeh CT, Tsai SH, Lee WH. Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis. Cancers (Basel) 2019;11:E786. [PMID: 31181620 DOI: 10.3390/cancers11060786] [Cited by in Crossref: 80] [Cited by in F6Publishing: 92] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 59 |
Kim HS, El-Serag HB. The Epidemiology of Hepatocellular Carcinoma in the USA. Curr Gastroenterol Rep. 2019;21:17. [PMID: 30976932 DOI: 10.1007/s11894-019-0681-x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 60 |
Schulte L, Scheiner B, Voigtländer T, Koch S, Schweitzer N, Marhenke S, Ivanyi P, Manns MP, Rodt T, Hinrichs JB, Weinmann A, Pinter M, Vogel A, Kirstein MM. Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma. Liver Int 2019;39:714-26. [PMID: 30663219 DOI: 10.1111/liv.14048] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 61 |
de Oliveira S, Houseright RA, Graves AL, Golenberg N, Korte BG, Miskolci V, Huttenlocher A. Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish. J Hepatol 2019;70:710-21. [PMID: 30572006 DOI: 10.1016/j.jhep.2018.11.034] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 62 |
Moraes AO, Nascimento EAD, Zubiolo TFM, Paula MFMD, Brito AFB, Petta BFV, Perini GM, Martins DR. Quimioembolização arterial transcateter de carcinoma hepatocelular em paciente com oclusão de tronco celíaco: um desafio terapêutico. J vasc bras 2019;18. [DOI: 10.1590/1677-5449.180090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 63 |
Kawaguchi T, Nakano D, Torimura T. Diabetes in Liver Disease. Alcoholic/Non-Alcoholic Digestive Diseases 2019. [DOI: 10.1007/978-981-13-1465-0_7] [Reference Citation Analysis]
|
| 64 |
Hung MH, Wang XW. Molecular Alterations and Heterogeneity in Hepatocellular Carcinoma. Molecular and Translational Medicine 2019. [DOI: 10.1007/978-3-030-21540-8_14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 65 |
Zheng Z, Zhang F, Gao D, Wu Y, Wu H. Gene expression profiles of rat MMECs with different glucose levels and fgl2 gene silencing. Diabetes Metab Res Rev 2018;34:e3058. [PMID: 30098304 DOI: 10.1002/dmrr.3058] [Reference Citation Analysis]
|
| 66 |
Li L, Liu X, Zhou L, Wang W, Liu Z, Cheng Y, Li J, Wei H. Autophagy Plays a Critical Role in Insulin Resistance- Mediated Chemoresistance in Hepatocellular Carcinoma Cells by Regulating the ER Stress. J Cancer 2018;9:4314-24. [PMID: 30519335 DOI: 10.7150/jca.27943] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 67 |
Mantovani A, Dauriz M, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis. Metabolism 2018;87:1-12. [PMID: 29935236 DOI: 10.1016/j.metabol.2018.06.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 13.4] [Reference Citation Analysis]
|
| 68 |
Uslu S, Alaca N, Kilic KD, Uysal A, Kurtel H. The effects of aerobic exercise frequencies on liver fibrosis, α-fetoprotein and cytokeratin 19 in experimental type 2 diabetes-induced rats: an immunohistochemistry study. Biotechnic & Histochemistry 2018;93:615-22. [DOI: 10.1080/10520295.2018.1517898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 69 |
Chen Y, Li X, Wu S, Ye W, Lou L. Metabolic syndrome and the incidence of hepatocellular carcinoma: a meta-analysis of cohort studies. Onco Targets Ther 2018;11:6277-85. [PMID: 30310291 DOI: 10.2147/OTT.S154848] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 70 |
Jarrar YB, Al-Essa L, Kilani A, Hasan M, Al-Qerem W. Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice. Diabetes Metab Syndr Obes 2018;11:483-92. [PMID: 30288071 DOI: 10.2147/DMSO.S172664] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 71 |
Ohuchi H, Inai K, Nakamura M, Park IS, Watanabe M, Hiroshi O, Kim KS, Sakazaki H, Waki K, Yamagishi H, Yamamura K, Kuraishi K, Miura M, Nakai M, Nishimura K, Niwa K; JSACHD Fontan Investigators. Mode of death and predictors of mortality in adult Fontan survivors: A Japanese multicenter observational study. Int J Cardiol 2019;276:74-80. [PMID: 30201381 DOI: 10.1016/j.ijcard.2018.09.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 72 |
Vicentini M, Ballotari P, Giorgi Rossi P, Venturelli F, Sacchettini C, Greci M, Mangone L, Pezzarossi A, Manicardi V. Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: An observational population-based study. Diabetes Research and Clinical Practice 2018;143:398-408. [DOI: 10.1016/j.diabres.2018.04.036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 73 |
Chen Y, Liu R, Chu Z, Le B, Zeng H, Zhang X, Wu Q, Zhu G, Chen Y, Liu Y, Sun F, Lu Z, Qiao Y, Wang J. High glucose stimulates proliferative capacity of liver cancer cells possibly via O-GlcNAcylation-dependent transcriptional regulation of GJC1. J Cell Physiol 2018;234:606-18. [PMID: 30078215 DOI: 10.1002/jcp.26803] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 74 |
Franklin R, Bispo RFM, Sousa-Rodrigues CF, Pires LAS, Fonseca A Jr, Babinski MA. Grape Leucoanthocyanidin Protects Liver Tissue in Albino Rabbits with Nonalcoholic Hepatic Steatosis. Cells Tissues Organs 2018;205:129-36. [PMID: 29913455 DOI: 10.1159/000489166] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 75 |
Kurinami N, Sugiyama S, Morita A, Yoshida A, Hieshima K, Miyamoto F, Kajiwara K, Jinnouch K, Jinnouchi T, Jinnouchi H. Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2018;139:122-30. [DOI: 10.1016/j.diabres.2018.02.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 76 |
de Oliveira S, Houseright RA, Graves AL, Golenberg N, Korte BG, Miskolci V, Huttenlocher A. High cholesterol diet modulates macrophage polarization and liver inflammation during early hepatocellular carcinoma progression in zebrafish.. [DOI: 10.1101/299016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 77 |
Zang S, Chen J, Song Y, Bai L, Chen J, Chi X, He F, Sheng H, Wang J, Xie S, Xie W, Yang Y, Zhang J, Zheng M, Zou Z, Wang B, Shi J; Chinese NAFLD Clinical Research Network (CNAFLD CRN). Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design. Adv Ther 2018;35:218-31. [PMID: 29411270 DOI: 10.1007/s12325-018-0670-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 78 |
Li X, Wang X, Gao P. Diabetes Mellitus and Risk of Hepatocellular Carcinoma. Biomed Res Int. 2017;2017:5202684. [PMID: 29379799 DOI: 10.1155/2017/5202684] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 79 |
Montagnana M, Lippi G. Cancer diagnostics: current concepts and future perspectives. Ann Transl Med 2017;5:268. [PMID: 28758094 DOI: 10.21037/atm.2017.06.20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
|
